Dow Jones Top Company Headlines at 11 PM ET: EverBank to Combine With WaFd to Create $75 Billion Bank | Robinhood ...
Dow Jones2026/09/08 03:00EverBank to Combine With WaFd to Create $75 Billion Bank
Florida-based EverBank Financial has reached a deal to pursue a reverse merger with the smaller bank in the Pacific Northwest.
----
Robinhood Wins a New Role in the Oura IPO: Underwriter
Playing an official part in the IPO process could give Robinhood more influence over the number of shares allocated to its customers.
----
Amazon Plane Crash Probe Examines Aircraft Speed, Runway Safeguards
The NTSB chairwoman said the Boeing jet careened 1,300 feet off the runway, hitting a van with seven people.
----
Chinese Company Draws Fire for Laying Off 100 Grads a Month After Hiring Them
The major auto parts maker landed in hot water with authorities as young people in the country face a bleak job market.
----
The World Can't Get Enough of These Japanese Sneakers
Onitsuka Tigers are having a moment as a weak yen and classic looks lure tourists to Tokyo stores.
----
A $2,000 iPhone is coming soon as Apple aims for high-end buyers
Apple's launch event on Wednesday is likely to feature the iPhone 18 and 18 Pro - as well as a foldable iPhone Ultra with a starting price near $2,000.
----
How Nvidia's Investment Juggernaut Can Jump from Big to Enormous
Nvidia has big investments in Intel, SpaceX and many more public companies. But its stakes in OpenAI and Anthropic are the real prize.
----
Volkswagen Factory to Become Defense Plant in Deal With Israel's Aurelius
Under the deal, investment company Aurelius would take over the plant as majority owner, together with the state of Lower Saxony.
----
CXMT Highlights Smartphone, AI Advances as Market Share Climbs
The Chinese memory-chip maker sought to reassure investors that it is gaining ground in higher-end memory markets, citing advances in smartphone and artificial-intelligence technologies.
----
Novo Nordisk Says Wegovy Shot Helped Children Lose Weight in Trial
The Danish drugmaker said the clinical trial met its primary goal after 68 weeks of treatment.
----
Novartis Shares Fall After Heart Drug Misses Target in Late-Stage Trial
The company said the late-stage study for its pelacarsen drug missed its primary objective of reducing the risk of cardiovascular events like death, heart attack and stroke compared with placebo.
(END) Dow Jones Newswires
September 07, 2026 23:00 ET (03:00 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Yelooo Integra Datanet corrects July securities holders registration report
Cakra Buana Resources Energi shareholder Republik Capital cuts stake to 9.3% from 11.3%
Preferred shares of South Korean companies are trading at a record 45% discount in ten years; Samsung's 110 trillion won buyback plan may help eliminate the "Korea discount"
Samsung Electronics' highly anticipated stock buyback plan is raising investor expectations that the South Korean giant will purchase non-voting preferred shares, narrowing their deep discount and setting a precedent for other companies.
Crypto prices
More
